Revumenib

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Revumenib topic overview

The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Revumenib.

Related topics: 19
Source areas: 5
Connected nodes: 24
Extracted relationships: 41
Related term clusters: 14
Bridge connections: 24

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Overview · 9 topics

Adverse effects · 4 topics

History · 3 topics

Medical uses · 2 topics

Society and culture · 1 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol): Interactive image
AHFS/Drugs.com: Monograph
ATC code: L01XX87 (WHO)
CAS Number: 2169919-21-3 · 2169919-22-4
ChEMBL: ChEMBL4650827 · ChEMBL4650278
ChemSpider: 95502909

Start with your topic. Discover where to go next.

Explore different angles and find fresh ideas to shape your next piece of content.

Revumenib

7Anti-cancer medication · Acute leukemia · KMT2A

12Food and Drug Administration · First-in-class medication · Indicated

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

Medical uses

Adverse effects

History

Society and culture

International nonproprietary name

For the semantics nerds

You can skip this section if you’re here for content ideas and keyword inspiration.

Advanced semantic analysis

How Revumenib connects Entity context

The extracted context around Revumenib shows recurring relationship patterns in the source. For example, Revumenib → AUGMENT-101, Drug Administration, Efficacy, FDA, NCT04065399, Participants, R/R, SNDX-5613-0700, The US Food Another extracted example is Revumenib → In October, KMT2A, NPM1. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to history · 9

Revumenib → AUGMENT-101, Drug Administration, Efficacy, FDA, NCT04065399, Participants, R/R, SNDX-5613-0700, The US Food

related to Medical uses · 3

Revumenib → In October, KMT2A, NPM1

CAS Number · 2

Revumenib → 2169919-21-3, 2169919-22-4

ChEMBL · 2

Revumenib → ChEMBL4650278, ChEMBL4650827

DrugBank · 2

Revumenib → DB18515, DBSALT003460

KEGG · 2

Revumenib → D12728, D12729

UNII · 2

Revumenib → 75HI05N8HS, LZ0M43NNF2

related to Legal status · 2

Revumenib → November, United States

3D model (JSmol) · 1

Revumenib → Interactive image

AHFS/Drugs.com · 1

Revumenib → Monograph

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

kmt2a treatment acute name us drug menin gene 2024 leukemias adverse medical revuforj administration leukemia lysine methyltransferase 2a differentiation syndrome

Revumenib relationships Subject–Predicate–Object triples

TTTA extracted 41 structured relationships around Revumenib. Examples in this analysis include Revumenib → 3D model (JSmol) → Interactive image and Revumenib → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Revumenib	3D model (JSmol)	Interactive image	1.00	infobox
Revumenib	AHFS/Drugs.com	Monograph	1.00	infobox
Revumenib	ATC code	L01XX87 (WHO)	1.00	infobox
Revumenib	CAS Number	2169919-21-3	1.00	infobox
Revumenib	CAS Number	2169919-22-4	1.00	infobox
Revumenib	ChEMBL	ChEMBL4650827	1.00	infobox
Revumenib	ChEMBL	ChEMBL4650278	1.00	infobox
Revumenib	ChemSpider	95502909	1.00	infobox
Revumenib	Drug class	Antineoplastic; menin inhibitor	1.00	infobox
Revumenib	DrugBank	DB18515	1.00	infobox
Revumenib	DrugBank	DBSALT003460	1.00	infobox
Revumenib	Formula	C32H47FN6O4S	1.00	infobox
Revumenib	KEGG	D12728	1.00	infobox
Revumenib	KEGG	D12729	1.00	infobox
Revumenib	Legal status	US: ℞-only	1.00	infobox
Revumenib	License data	US DailyMed: Revumenib	1.00	infobox
Revumenib	MedlinePlus	a624077	1.00	infobox
Revumenib	Molar mass	630.82 g·mol−1	1.00	infobox
Revumenib	Other names	SNDX-5613	1.00	infobox
Revumenib	PDB ligand	OQ4 (PDBe, RCSB PDB)	1.00	infobox
Revumenib	Pronunciation	/rɪˈvuːmɛnɪb/ rih-VOO-meh-nib	1.00	infobox
Revumenib	PubChem CID	132212657	1.00	infobox
Revumenib	Routes of administration	By mouth	1.00	infobox
Revumenib	Trade names	Revuforj	1.00	infobox
Revumenib	UNII	LZ0M43NNF2	1.00	infobox
Revumenib	UNII	75HI05N8HS	1.00	infobox

Related concept clusters Related term clusters

The concept neighborhoods around Revumenib bring nearby vocabulary together. In this analysis, examples include Treatment, Medical and Gene. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Revumenib
- Treatment
- Medical
- Gene
- Kmt2a
- Name
- Acute
- 2a
- Administration
- Leukemias
- Lysine
- Methyltransferase
- Mutation
revumenib
- Treatment
- Medical
- Gene
- Kmt2a
- Name
- Acute
- 2a
- Administration
- Leukemias
- Lysine
- Methyltransferase
- Mutation
acute leukemias
- Leukemia
- Kmt2a
- Mll
- Treatment
- 2a
- Lysine
- Methyltransferase
- Refractory
- Relapsed
- Gene
- Menin
- Revuforj
kmt2a
- Leukemias
- Mll
- Lysine
- Menin
- Methyltransferase
- Revuforj
- Name
- Treatment
- Legal
- Names
- Revumenib
- Status
international nonproprietary name
- Revuforj
- Sold
- 2a
- Lysine
- Methyltransferase
- Gene
- Kmt2a
- Acute
- Treatment
- Legal
- Names
- Revumenib
adverse effects
- Common
- Reactions
- Differentiation
- Syndrome
- Legal
- Names
- Status
- Mouth
- Administration
- Lysine
- Medical
- Menin
food and drug administration
- Administration
- Drug
- Us
- Legal
- Names
- Status
- Medication
- Mouth
- Adverse
- Lysine
- Medical
- Menin
orphan drug
- Administration
- Us
- Legal
- Names
- Status
- Medication
- Mouth
- Lysine
- Medical
- Menin
- Methyltransferase
- Refractory

Connections between topic areas Semantic bridges

For Revumenib, one of the stronger structural bridges in this analysis connects Revumenib with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Revumenib — Overview · splits 15 ⟂ 10

Revumenib — Adverse effects · splits 20 ⟂ 5

Revumenib — History · splits 21 ⟂ 4

Revumenib — Medical uses · splits 22 ⟂ 3

Map overview Semantic statistics

Revumenib

Nodes25

Edges24

Triples41

Avg. degree1.92

Density0.08

Components1

Source & methodology

TTTA analyzes the structure around Revumenib to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Revumenib · EN edition · Analysis: TopicsToTalkAbout

Revumenib: History, Community, Culture & Applications

Revumenib topic overview

What this topic covers Research coverage

Key facts & relationships

Start with your topic. Discover where to go next.

Questions to explore

Explore all related topics Closing gaps

Overview

Medical uses

Adverse effects

History

Society and culture

For the semantics nerds

Advanced semantic analysis

How Revumenib connects Entity context

Revumenib

Top relations

Important terminology

Important terminology

Revumenib relationships Subject–Predicate–Object triples

Related concept clusters Related term clusters

Connections between topic areas Semantic bridges

Map overview Semantic statistics

Revumenib

Source & methodology